Green A R
Imperial Cancer Research Fund Laboratories, St Bartholomew's Hospital, London, UK.
Br J Cancer. 1988 Aug;58(2):115-21. doi: 10.1038/bjc.1988.176.
It is increasingly recognised that recessive mutations play an important role in the pathogenesis of many forms of malignancy. Some of the affected loci may prove to be recessively-activated proto-oncogenes, but others are now known to be tumorigenic solely by virtue of their loss or inactivation and therefore form a distinct and novel family of tumour genes. Preliminary evidence suggests that such genes are likely to be functionally heterogeneous and to encode molecules involved in the inhibition of cellular proliferation and/or the induction of differentiation. Their further study is likely to illuminate fundamental mechanisms of normal cellular growth and differentiation as well as having important implications for the pathogenesis and management of cancer.
越来越多的人认识到,隐性突变在多种恶性肿瘤的发病机制中起着重要作用。一些受影响的基因座可能被证明是隐性激活的原癌基因,但现在已知其他一些基因座仅因其缺失或失活而具有致瘤性,因此形成了一个独特的新型肿瘤基因家族。初步证据表明,这类基因在功能上可能具有异质性,并编码参与抑制细胞增殖和/或诱导分化的分子。对它们的进一步研究可能会阐明正常细胞生长和分化的基本机制,同时对癌症的发病机制和治疗也具有重要意义。